What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Otto C. Boerman mainly focuses on Pathology, Internal medicine, Biodistribution, Monoclonal antibody and Positron emission tomography.
His studies in Pathology integrate themes in fields like Preclinical imaging and Inflammation.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Gene expression, Small interfering RNA, Gene silencing and Peptide.
His work deals with themes such as Ex vivo, Single-photon emission computed tomography, Pancreas, Receptor and Glucocorticoid, which intersect with Biodistribution.
His Monoclonal antibody research entails a greater understanding of Antibody.
His Radioimmunotherapy study combines topics from a wide range of disciplines, such as Cancer research and Heterologous.
His most cited work include:
- Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy (682 citations)
- Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state (443 citations)
- Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies (372 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Pathology, Biodistribution, Cancer research, Internal medicine and Antibody.
The Pathology study combines topics in areas such as Ex vivo, Monoclonal antibody and Positron emission tomography.
His biological study spans a wide range of topics, including Nude mouse, Antigen and Fluorescence-lifetime imaging microscopy.
His research integrates issues of LNCaP and Pharmacology in his study of Biodistribution.
His Cancer research study combines topics in areas such as Cancer, Prostate cancer and Immunotherapy.
Otto C. Boerman works mostly in the field of Internal medicine, limiting it down to topics relating to Endocrinology and, in certain cases, Radionuclide therapy.
He most often published in these fields:
- Pathology (30.67%)
- Biodistribution (21.95%)
- Cancer research (21.45%)
What were the highlights of his more recent work (between 2015-2021)?
- Pathology (30.67%)
- Cancer research (21.45%)
- Biodistribution (21.95%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pathology, Cancer research, Biodistribution, In vitro and Nuclear medicine.
His Pathology study integrates concerns from other disciplines, such as Ex vivo, Integrin, Antibody and Arthritis.
His Cancer research research includes themes of Cancer, Prostate cancer, Hypoxia, Chemotherapy and Photodynamic therapy.
His Biodistribution research is multidisciplinary, relying on both Molecular biology, Monoclonal antibody, Pancreas and Fluorescence-lifetime imaging microscopy.
His In vitro research includes elements of Calcium, Chelation, Receptor, Internalization and Pharmacology.
His work carried out in the field of Nuclear medicine brings together such families of science as Clear cell renal cell carcinoma, Renal cell carcinoma, Beta cell and Distribution.
Between 2015 and 2021, his most popular works were:
- 89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry. (54 citations)
- Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent. (51 citations)
- Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study. (45 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary scientific interests are in Pathology, Biodistribution, Fluorescence-lifetime imaging microscopy, Cancer research and Ex vivo.
He has researched Pathology in several fields, including Antibody and Radionuclide therapy.
Otto C. Boerman studied Biodistribution and Molecular imaging that intersect with Colorectal cancer and Labetuzumab.
His Fluorescence-lifetime imaging microscopy research is multidisciplinary, incorporating elements of Immunohistochemistry, Gamma probe, Surgery, Kidney and Monoclonal antibody.
His research in Monoclonal antibody is mostly concerned with Radioimmunotherapy.
His study in Cancer research is interdisciplinary in nature, drawing from both Prostate cancer, Spleen, Calcification, Radiation therapy and Nanocarriers.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
